THERAPIES FOR TREATING PROCTITIS WITH POLYCLONAL ANTI-TNFALPHA ANTIBODIES

The present invention is directed to an antibody composition for use in treating proctitis, wherein the antibody composition comprises intact blood-derived polyclonal antibodies that bind to a human tumour necrosis factor α (TNFα). The invention also relates to associated uses, methods, solid compos...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	COXON, Ruth Elizabeth, LANDON, John
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention is directed to an antibody composition for use in treating proctitis, wherein the antibody composition comprises intact blood-derived polyclonal antibodies that bind to a human tumour necrosis factor α (TNFα). The invention also relates to associated uses, methods, solid compositions, and liquid compositions using/comprising the same. La présente invention concerne une composition d'anticorps destinée à être utilisée dans le traitement de la proctite, la composition d'anticorps comprenant des anticorps polyclonaux dérivés du sang intacts qui se lient à un facteur de nécrose tumorale alpha (TNFα) humain. L'invention concerne également des utilisations associées, des procédés, des compositions solides et des compositions liquides les utilisant/comprenant.